In recent years, there has been an explosive growth of biopharmaceutical and clinical research, including the development of new medicines for treating severe or life-threatening diseases. Biopharmaceutical statistics plays an extremely important role in ensuring not only the efficacy and safety of the medicine under investigation, but also that the pharmaceutical product possesses good drug characteristics, such as identity, strength, purity, quality, stability, and reproducibility. Widely used by pharmaceutical scientists, clinical researchers, and biostatistics, the Encyclopedia of Biopharmaceutical Statistics, Third Edition is an essential resource on the evolving state of this important field.
New to the Third Edition
- 89 new chapters, bringing the total number of chapters to 230
- Updated information on changes in regulatory requirements for drug review/approval processes
- Recent developments in statistical design and methodology
- Important topics, including adaptive design in clinical research, translational medicine, statistical genetics, biomarker development, target clinical trials, follow-on biologics, and traditional Chinese medicine
Also Available Online
This Taylor & Francis encyclopedia is also available through online subscription, offering a variety of extra benefits for researchers, students, and librarians, including:
? Citation tracking and alerts
? Active reference linking
? Saved searches and marked lists
? HTML and PDF format options
Contact Taylor and Francis for more information or to inquire about subscription options and print/online combination packages.
US: (Tel) 1.888.318.2367; (E-mail) e-reference@taylorandfrancis.com
International: (Tel) +44 (0) 20 7017 6062; (E-mail) online.sales@tandf.co.uk
